MEDI-3617

N/A

Report date: 2025/09/23 20:00:05

Base Information

Drug NameMEDI-3617
Drug Alias NameMEDI-3617ANG-2-mAbAnti-ANG-2-mAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAngiopoietin-2 inhibitors
TargetsAngiopoietin-2
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsSolid tumoursOvarian NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A